• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Tuesday, July 15, 2025
  • Login
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home Business

Pfizer Is getting into Cannabis with $6.7B Arena Pharma deal

by Aashish Sehrawat
December 16, 2021
in Business, News, Popular
Reading Time: 2 mins read
0
Six more women file lawsuits against Tesla, allege sexual harassment worsened by Musk’s tweets

Image: FOrbes

TwitterWhatsappLinkedin
Image: FOrbes

Pfizer Inc., the world’s largest pharmaceutical company, has acquired Arena Pharmaceuticals, Inc. for $6.7 billion. The two publicly traded firms announced on Monday that they have inked a formal deal under which Pfizer would pay $100 per share in cash for all outstanding shares of Arena.

You might also like

Nintendo Switch Piracy Hub Nsw2u Taken Down in FBI Crackdown

France Investigates X Over Algorithm Changes Amid Fears of Foreign Interference

Tesla Slashes Model Y Price by $20,000 in Canada as Tariffs and Sales Woes Mount

Pfizer aims to fund the deal with cash on hand once all regulatory approvals have been obtained.

Arena Pharmaceuticals, situated in San Diego, California, is a biotech business with a cannabinoid-type medicines component in its pipeline. The research and development of Olorinab, an experimental medication candidate, is at the heart of its cannabis biotech operations (APD371).

This is an oral cannabinoid receptor 2 full agonist that is being studied for the treatment of a variety of symptoms, with a focus on visceral discomfort associated with gastrointestinal diseases.

Arena’s therapeutic pipeline is primarily focused on non-cannabinoid pharmaceuticals, with the goal of creating novel potential therapies for the treatment of a variety of immuno-inflammatory illnesses. Arena’s development-stage treatment candidates in gastrointestinal, dermatology, and cardiology are diverse and promising.

Mike Gladstone, global president and general manager, Pfizer Inflammation and Immunology, said, “The proposed acquisition of Arena complements our capabilities and expertise in Inflammation and Immunology, a Pfizer innovation engine developing potential therapies for patients with debilitating immuno-inflammatory diseases with a need for more effective treatment options.”

“We plan to speed the clinical development of etrasimod for patients with immuno-inflammatory illnesses by leveraging Pfizer’s outstanding research and worldwide development capabilities.” Arena’s therapeutic candidate for treating immune-mediated and inflammatory illnesses is etrasimod.

Arena’s president and CEO, Amit D. Munshi, expressed his delight at the company’s acquisition by Pfizer, which saw “Arena’s potentially best-in-class S1P molecule and our contribution to addressing unmet needs in immune-mediated inflammatory diseases.” Pfizer’s capabilities will help us achieve our aim of obtaining important medicines to patients quicker. This transaction, we believe, is the best next step for both patients and shareholders.”

This isn’t the first time one of the world’s major pharmaceutical companies has invested in a cannabis-related business. Jazz Pharmaceuticals purchased GW Pharmaceuticals, a cannabinoid medical business notable for creating Epidiolex, the first FDA-approved CBD medicine for treating adolescents with severe types of epilepsy, in February 2021.

The drug was first licenced for the treatment of seizures linked to Lennox-Gastaut syndrome and Dravet syndrome, and then for tuberous sclerosis complex seizures last July.

Last year, Epidiolex sales totaled more than $500 million.

Tilray, a Canadian cannabis company, signed a supply and distribution partnership with pharmaceutical giant Novartis AG in 2018.

Tags: #pFizercannabismedmedicinePharmathc
Tweet54SendShare15
Previous Post

Grindr was fined heavily for sharing user data without consent

Next Post

Apple postpones the reopening and is giving every employee $1,000 bonus

Aashish Sehrawat

Recommended For You

Nintendo Switch Piracy Hub Nsw2u Taken Down in FBI Crackdown

by Harikrishnan A
July 15, 2025
0
Nintendo Switch Piracy Hub Nsw2u Taken Down in FBI Crackdown

A well-known website catering to Nintendo Switch piracy, Nsw2u, has been permanently taken offline following an investigation led by the FBI. The site, widely used for downloading illegal...

Read more

France Investigates X Over Algorithm Changes Amid Fears of Foreign Interference

by Harikrishnan A
July 15, 2025
0
European Union Commences Investigation into Social Media Firm X for Alleged DSA Violations

French authorities have opened a formal investigation into the social media platform X—formerly known as Twitter—amid allegations that its algorithm may have been manipulated to support foreign interference...

Read more

Tesla Slashes Model Y Price by $20,000 in Canada as Tariffs and Sales Woes Mount

by Harikrishnan A
July 15, 2025
0
Tesla Owner Burns Down Car and House After Plugging Directly Into Power Line

Tesla is in crisis management mode in Canada, cutting the price of its Model Y SUV by a staggering CAD $20,000 in an urgent attempt to recover from...

Read more
Next Post
Apple Inc.

Apple postpones the reopening and is giving every employee $1,000 bonus

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]

Advertise With Us

Reach out at - [email protected]

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple Artificial Intelligence bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News NFT samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2024 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2024 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?